Participants randomized to this arm will receive a standardized Vitality program aimed at promoting tobacco cessation. This program includes existing employee benefits for quitting and the use of text/email messages to encourage tobacco cessation. No incentives will be given to participants randomized to this arm. Free cessation aids will not be available to participants in this arm. They will receive compensation for completing study related activities (sample submissions).

Participants randomized to this experimental arm will receive the standardized program including text/email messaging and will have access to free e-cigarettes only. These products can be ordered directly, free of charge, through the web-based interface. No incentives will be given to participants randomized to this arm. They will receive compensation for completing study related activities (sample submissions).

Participants randomized to this experimental arm will receive the standardized program including text/email messaging and will have access to free e-cigarettes, conventional Nicotine Replacement Therapy (NRT), Zyban, or Chantix. Each of these can be ordered directly, free of charge, through the web-based interface. No incentives will be given to participants randomized to this arm. They will receive compensation for completing study related activities (sample submissions).

Participants randomized to this experimental arm will receive the standardized program and access to free e-cigarettes, NRT, Zyban, or Chantix. In addition, they will also be able to earn incentives across six months for testing negative for tobacco use (see Incentive payout, below). They will also receive compensation for completing study related activities (sample submissions).

Participants randomized to this experimental arm will receive the standardized program and access to free e-cigarettes, NRT, Zyban, or Chantix. In addition they will also be able to earnincentives across six months through a pre-funded deposit or precommitment account. They will be notified that money has been placed into an account for them. At each time point they will lose a portion (see below) of this initial funding if they do not provide biochemical evidence of abstinence. They will also receive compensation for completing study related activities (sample submissions).

Smoking Cessation

Participants in this arn will be given free access to e-cigarettes to help quit smoking

E-cigarette free access

Participants in this arn will be given free access to cessation aids to help quit smoking

E-cigarette/NRT/Zyban/Chantix Choice

Participants in this arm will be earn incentives across 6 months for verified abstinence.

Outcome Incentive arm

Participants in this arm will be told they have a pre-funded account with money that is theirs if they quit smoking.

Loss framing incentive arm

Participants will have access to information and advice on quitting smoking. This is a control and no actual intervention will be applied.

Control

University of Pennsylvania

Randomized Clinical Trial to Reduce Harm From Tobacco

Biometric testing (metabolites of nicotine) at 6 months following the quit date

Biometric testing (metabolites of nicotine) at 1 month, 3 months, and 12 months following the quit date.

anabasine/gojaznost

Randomized Clinical Trial to Reduce Harm From Tobacco

Najkompletnija baza ljekovitog bilja potpomognuta naukom